Kite Pharma Inc (NASDAQ:KITE) - Share price - Overview

Stock Report

Kite Pharma Inc KITE

Last Price
$130.18

Day Change
4.15|3.29%

As of 18/08/2017
19:56:28 EDT | USD
Minimum 15 Minutes Delay.

Last Close126.03
Day Range124.10 - 130.64
Mkt Cap7.44Bil
52-Wk Range39.82 - 130.64
Yield %-
ISINUS49803L1098
Volume1,058,415
P/E-18.76
P/S208.33
P/CF-43.14

Share Price

Financials
201420152016
More ...
Income Statement
Revenue0.0017.2622.17
Operating Income-36.66-103.32-273.19
Net Income-42.57-101.65-267.07
Basic EPS-1.91-2.33-5.46
Avg. Diluted Shares Outstanding234449
Balance Sheet
Current Assets368.37631.09427.40
Non Current Assets2.3876.8796.91
Total Assets370.75707.96524.30
Current Liabilities6.7336.1755.14
Total Liabilities8.1692.2096.33
Total Equity362.59615.76427.97
Cash Flow
Operating Cash Flow-17.07-16.09-168.90
Capital Expenditure-2.10-26.57-20.15
Free Cash Flow-19.17-42.66-189.05

In millions, except "Basic EPS". Currency is USD.

Company Profile

Kite Pharma Inc is a clinical-stage biopharmaceutical company. It is engaged in the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Mid-Growth

Fiscal Year Ends

December

Employees

447
Key Stats
More ...
Price/Earning TTM-18.16
Price/Book10.16
Price/Sales TTM233.00
Rev Growth (3 year avg)-
EPS Growth (3 year avg)-
Operating Margin % TTM-1,232.24
Net Margin % TTM-1,204.65
ROE TTM-51.18
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.